Systematic review / meta-analysis / 2015
Coenzyme Q10 supplementation did not significantly improve statin-induced myopathy in randomized trials.
A meta-analysis of six randomized controlled trials evaluated 302 patients receiving statin therapy to assess coenzyme Q10 supplementation for statin-induced myopathy. Supplementation did not significantly alter plasma creatine kinase activity compared to control (mean difference: 11.69 U/L, 95% CI: -14.25 to 37.63, P = .38). Furthermore, coenzyme Q10 did not significantly reduce muscle pain (standardized mean difference: -0.53, 95% CI: -1.33 to 0.28, P = .20).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 302 patients receiving statin therapy across 6 randomized controlled trials
- What was measured
- Plasma creatine kinase activity and muscle pain
THE PAPER
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.
Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Lip GY, Dragan S, Mikhailidis DP, Lipid and Blood Pressure Meta-analysis Collaboration Group. Mayo Clin Proc, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.